Despite the availability of curative direct acting antiviral (DAA) therapies, most people who are newly diagnosed with hepatitis C (HCV) do not receive treatment, an Australian study has found. About a third of people who are newly diagnosed with HCV are lost to follow up or unable to access therapy because they are in prison, ...
Most people diagnosed with HCV don’t receive DAA treatment
By Michael Woodhead
1 Oct 2020